State MN
Clinical Trials in Minnesota
Recruiting clinical trials with at least one study location in Minnesota. Data updated daily from ClinicalTrials.gov.
Top Conditions in Minnesota
NCT05946629 N/A
Recruiting
SELUTION 4 De Novo Small Vessel IDE Trial
Condition
Coronary Artery Disease
Enrollment
960 pts
Location
United States
Sponsor
M.A. Med Alliance S.A.
NCT07007065 Phase 3
Recruiting
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
561 pts
Location
United States, Austria, Belgium
Sponsor
AbbVie
NCT05673200 Phase 1
Recruiting
Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine),...
Condition
Anatomic Stage III Breast Cancer AJCC v8
Enrollment
32 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05411029 N/A
Recruiting
Study of Disrupted Sleep in Somali Americans
Condition
Hypertension
Enrollment
240 pts
Location
United States
Sponsor
Mayo Clinic
NCT05467150 N/A
Recruiting
Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic ...
Condition
Infant of Diabetic Mother
Enrollment
60 pts
Location
United States
Sponsor
University of Minnesota
NCT07007559 Phase 1, Phase 2
Recruiting
ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Adv...
Condition
Breast Cancer, Metastatic
Enrollment
80 pts
Location
United States
Sponsor
ALX Oncology Inc.
NCT02958462 N/A
Recruiting
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Condition
Myeloid Malignancy
Enrollment
2,000 pts
Location
United States
Sponsor
Mayo Clinic
NCT06770062 N/A
Recruiting
Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation:...
Condition
Left Ventricular Systolic Dysfunction
Enrollment
30 pts
Location
United States
Sponsor
Mayo Clinic
NCT07209462 Phase 2
Recruiting
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
Condition
Fragile X Syndrome
Enrollment
60 pts
Location
United States
Sponsor
Mirum Pharmaceuticals, Inc.
NCT02437396 N/A
Recruiting
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
Condition
Gaucher Disease Type I
Enrollment
34 pts
Location
United States
Sponsor
University of Minnesota
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07221851 Phase 3
Recruiting
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared...
Condition
Turner Syndrome
Enrollment
186 pts
Location
United States
Sponsor
Ascendis Pharma A/S
NCT04867837 Phase 3
Recruiting
Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Fac...
Condition
Acute Major Bleeding
Enrollment
260 pts
Location
United States, Austria, Bosnia and Herzegovina
Sponsor
Octapharma
NCT06068075 N/A
Recruiting
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Dia...
Condition
Ewing Sarcoma
Enrollment
340 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT06868212 Phase 3
Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Time...
Condition
Chronic Spontaneous Urticaria (CSU)
Enrollment
400 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
NCT05917145 Phase 1
Recruiting
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Rec...
Condition
Glioblastoma
Enrollment
94 pts
Location
United States
Sponsor
Mayo Clinic
NCT05705453 N/A
Recruiting
Epidural Stimulation After Neurologic Damage: Long-Term Outcomes
Condition
SCI - Spinal Cord Injury
Enrollment
50 pts
Location
United States
Sponsor
University of Minnesota
NCT07075731 N/A
Recruiting
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming H...
Condition
Cancer Screening
Enrollment
40 pts
Location
United States
Sponsor
University of Minnesota
NCT06310291 EARLY_Phase 1
Recruiting
VTP-1000 in Adults With Celiac Disease
Condition
Celiac Disease
Enrollment
45 pts
Location
United States
Sponsor
Barinthus Biotherapeutics
NCT01970696 N/A
Recruiting
International Ovarian & Testicular Stromal Tumor Registry
Condition
Ovarian Sex-cord Stromal Tumor
Enrollment
300 pts
Location
United States
Sponsor
Children's Hospitals and Clini
NCT06112613 N/A
Recruiting
Mobile Health for Adherence in Breast Cancer Patients
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
410 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT04373317 Phase 4
Recruiting
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Condition
Parkinson's Disease Psychosis
Enrollment
358 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT03903510 N/A
Recruiting
Virtual Reality During Pediatric Cast Removal
Condition
Fractures, Bone
Enrollment
184 pts
Location
United States
Sponsor
Gillette Children's Specialty
NCT06996782 Phase 1, Phase 2
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Condition
Advanced or Metastatic Non-small Cell Lung Cancer
Enrollment
152 pts
Location
United States, Belgium, Brazil
Sponsor
AstraZeneca